Johnson & Johnson (JNJ) Issues FY17 Earnings Guidance
Johnson & Johnson (NYSE:JNJ) updated its FY17 earnings guidance on Tuesday. The company provided earnings per share (EPS) guidance of $7.12-7.22 for the period, compared to the Thomson Reuters consensus estimate of $7.11. The company issued revenue guidance of $75.8-76.1 billion, compared to the consensus revenue estimate of $75.65 billion.
Several analysts recently issued reports on the company. UBS AG reiterated a buy rating and issued a $136.00 price target on shares of Johnson & Johnson in a report on Monday, May 15th. Vetr upgraded Johnson & Johnson from a hold rating to a buy rating and set a $132.33 price target for the company in a report on Thursday, May 18th. Stifel Nicolaus reiterated a hold rating and issued a $128.00 price target (up from $124.00) on shares of Johnson & Johnson in a report on Thursday, May 18th. BidaskClub upgraded Johnson & Johnson from a buy rating to a strong-buy rating in a report on Saturday, June 17th. Finally, Wells Fargo & Company reiterated a market perform rating and issued a $135.00 price target (up from $132.00) on shares of Johnson & Johnson in a report on Thursday, July 6th. Eleven equities research analysts have rated the stock with a hold rating and ten have issued a buy rating to the stock. The stock presently has an average rating of Hold and a consensus target price of $133.65.
Shares of Johnson & Johnson (NYSE:JNJ) opened at 132.15 on Tuesday. The stock’s 50 day moving average price is $130.42 and its 200-day moving average price is $122.68. Johnson & Johnson has a 12-month low of $109.32 and a 12-month high of $137.00. The company has a market cap of $355.99 billion, a PE ratio of 22.21 and a beta of 0.78.
Johnson & Johnson (NYSE:JNJ) last released its quarterly earnings results on Tuesday, July 18th. The company reported $1.83 EPS for the quarter, beating the Zacks’ consensus estimate of $1.79 by $0.04. The firm had revenue of $18.84 billion for the quarter, compared to analyst estimates of $18.94 billion. Johnson & Johnson had a net margin of 22.87% and a return on equity of 26.50%. The company’s revenue for the quarter was up 1.9% compared to the same quarter last year. During the same period in the previous year, the business earned $1.74 earnings per share. On average, equities research analysts forecast that Johnson & Johnson will post $7.10 earnings per share for the current year.
The company also recently declared a quarterly dividend, which will be paid on Tuesday, September 12th. Shareholders of record on Tuesday, August 29th will be given a $0.84 dividend. The ex-dividend date is Friday, August 25th. This represents a $3.36 dividend on an annualized basis and a yield of 2.54%. Johnson & Johnson’s dividend payout ratio (DPR) is presently 56.47%.
About Johnson & Johnson
Johnson & Johnson is a holding company, which is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. It operates through three segments: Consumer, Pharmaceutical and Medical Devices. Its primary focus is products related to human health and well-being.
Receive News & Ratings for Johnson & Johnson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson & Johnson and related companies with MarketBeat.com's FREE daily email newsletter.